Vertex Pharma (VRTX) – Trading Halts
-
Vertex (VRTX) and Molecular Templates (MTEM) Establish Pact to Discover, Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants
-
Vertex Pharma (VRTX) Confirms FDA Approves TRIKAFTA to Treat Underlying Cause of CF in People Ages 12 and Older Who Have at Least One F508del Mutation
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to VRTX Stock Lookup